Home › Funds › Verdad Advisers, LP › XFOR
Verdad Advisers, LP position in XFOR
X4 PHARMACEUTICALS INC · Health Care
Verdad Advisers, LP reported holding 352,093 shares of XFOR (X4 PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$1.6M, representing 1.57% of its reported portfolio and ranking #10 among its reported holdings. Verdad Advisers, LP first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Verdad Advisers, LP's XFOR position evolved
Verdad Advisers, LP first disclosed a stake in XFOR in Q2 2026 at 352,093 shares (US$1.6M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 352.09K | $1.64M | New |
About XFOR and 13F data
XFOR (X4 PHARMACEUTICALS INC) is a Health Care company. 40 other funds we track also report a position in XFOR — the largest reported positions include Bain Capital Life Sciences Investors, LLC (US$37.2M), PERCEPTIVE ADVISORS LLC (US$37.0M), Saturn V Capital Management LP (US$32.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding XFOR
- Bain Capital Life Sciences Investors, LLC 7.97M sh · $37.21M · Q2 2026
- PERCEPTIVE ADVISORS LLC 7.93M sh · $37.05M · Q2 2026
- Saturn V Capital Management LP 6.97M sh · $32.57M · Q2 2026
- Empery Asset Management, LP 6.93M sh · $32.37M · Q2 2026
- Deep Track Capital, LP 5.88M sh · $27.45M · Q2 2026
- Kalehua Capital Management LLC 3.72M sh · $17.39M · Q2 2026
- NEA Management Company, LLC 3.23M sh · $15.10M · Q2 2026
- Rosalind Advisors, Inc. 3.21M sh · $15.01M · Q2 2026
- Trails Edge Capital Partners, LP 2.57M sh · $12.01M · Q2 2026
- BVF INC/IL 2.23M sh · $10.43M · Q2 2026
- Venrock Adviser, LLC 1.93M sh · $9.03M · Q2 2026
- Samsara BioCapital, LLC 1.40M sh · $6.52M · Q2 2026
More on Verdad Advisers, LP
FAQ
How long has Verdad Advisers, LP held XFOR?
Verdad Advisers, LP has disclosed XFOR holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Verdad Advisers, LP's current position in XFOR?
As of Q2 2026, Verdad Advisers, LP holds 352.09K shares of XFOR (X4 PHARMACEUTICALS INC), valued at $1.64M, representing 1.57% of its reported portfolio and ranking #10.
Has Verdad Advisers, LP been buying or selling XFOR?
In the latest 13F filing (Q2 2026), Verdad Advisers, LP newly opened its position in XFOR.
Which other funds hold XFOR?
Other major institutional holders of XFOR include Bain Capital Life Sciences Investors, LLC, PERCEPTIVE ADVISORS LLC, Saturn V Capital Management LP, among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.